What Happened? Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 7.2% in the afternoon session after the ...

Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 5.9% in the afternoon session after the company reached an agreement with the U.S. government to lower drug prices and reported ...

Pfizer (PFE) shares may have broken out. This means a large amount of supply has come off the market. This is bullish.

Pfizer (PFE) closed at $25.24 in the latest trading session, marking a -1.71% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.28% for the day. Elsewhere, the ...

On Tuesday, Pfizer and President Donald Trump announced the company had signed an agreement under which the pharmaceutical ...

Pfizer surged after striking a landmark agreement with the Trump administration to lower drug prices and expand U.S. production.

Bowing to pressure from Washington, the company is preparing to announce price cuts on drugs for U.S. customers.

While stocks sagged in the daily session, the major indexes were headed for monthly gains as September trade wraps up. The Dow Jones Industrial Average looked set to add more than 1.5% and the Nasdaq ...

CoreWeave, backed by Nvidia, gained 11.7% today after it secured a $14.2 billion long-term cloud deal with Meta platforms.

But -- finally -- Pfizer is getting into the obesity drug game. This past week, the company announced it will acquire Metsera, a clinical-stage biopharmaceutical firm that is developing several ...

Pfizer Inc. (NYSE: PFE) experienced a significant uptick in its stock price following two major announcements on September 30 ...

Pfizer Inc. remains attractive with strong fundamentals, cost control, an expanding market, and new drugs. Click here to read ...